Therapeutic Asset Ratings
462 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Ono-7914
Neoplasm
Ono Pharmaceutical Co., Ltd.
P1
C
(36)
Ot-A201
Neoplasm
Onward Therapeutics
P1
C
(36)
pb101
Neoplasm
Panolos Bioscience
P1
C
(36)
PIMURUTAMAB
Neoplasm
Shanghai Henlius Biotech
P1
C
(36)
PIN
Neoplasm
Chinese PLA General Hospital
P1
C
(36)
pt0253
Neoplasm
PAQ Therapeutics, Inc.
P1
C
(36)
pt0511
Neoplasm
PAQ Therapeutics, Inc.
P1
C
(36)
Ptx-912
Neoplasm
Proviva Therapeutics, Inc.
P1
C
(36)
qlf31907
Neoplasm
Qilu Pharmaceutical Co., Ltd.
P1
C
(36)
QN302
Neoplasm
Qualigen Theraputics, Inc.
P1
C
(36)
r-5780
Neoplasm
Rise Therapeutics LLC
P1
C
(36)
Radvax
Neoplasm
Vaxine Pty Ltd
P1
C
(36)
Rose12
Neoplasm
Chugai Pharmaceutical
P1
C
(36)
rt001
Solid Tumor
Wuxi People's Hospital
P1
C
(36)
ryz401
Neoplasm
RayzeBio, Inc.
P1
C
(36)
sb17170
Neoplasm
SPARK Biopharma
P1
C
(36)
Scr-6920
Neoplasm
Jiangsu Simcere Pharmaceutical Co., Ltd.
P1
C
(36)
Setidegrasib
Neoplasm
Astellas Pharma Inc
P1
C
(36)
Shr-A1811 For
Neoplasm
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
P1
C
(36)
Si-B036
Neoplasm
Sichuan Baili Pharmaceutical Co., Ltd.
P1
C
(36)
Son-Dp
Neoplasm
Qurgen Inc.
P1
C
(36)
SPX-303
Neoplasm
SparX Biotech(Jiangsu) Co., Ltd.
P1
C
(36)
Sti-1386
Neoplasm
Sorrento Therapeutics, Inc.
P1
C
(36)
Sti-6643
Neoplasm
Sorrento Therapeutics, Inc.
P1
C
(36)
STP707
Neoplasm
Sirnaomics
P1
C
(36)
Showing 376 to 400 of 462 assets
Previous
Page 16 of 19
Next